Category: New products
-

Engineered Moth to Control Soybean Pest
A company providing genetically engineered insects to control threats to health and agriculture is designing a modified moth that now destroys soybeans and other crops.
-

Human Heart 3-D Printed from Patient Cells
A biomedical engineering team printed a three-dimensional scale model of a human heart, including blood vessels, from cells donated by a living person.
-

Start-Up Analyzes Images to Determine Medical Condition
A new company provides a service that determines a person’s condition for disease treatments based on indicators derived from an analysis of huge medical-image databases.
-

Lung Model Developed to Test E-Cigarettes, Hookah
A three-dimensional model of a human lung is being developed to test health effects of new trends in smoking, such as electronic cigarettes and hookahs.
-

Resistant Fungus Treatment Shown Effective in Early Results
Results from a clinical trial show an experimental anti-fungal drug effective in 2 cases of Candida auris infections, a fungus resistant to most other drugs.
-

Human-Friendly Robot Designed for A.I.
A robotics team at University of California in Berkeley designed a device to learn about humans’ needs with artificial intelligence and respond gently to their presence.
-

Autonomous Robots Designed for Flood Projects
As towns and cities face more threats of floods from climate change, a new type of autonomous robot offers a technology to help prevent or contain the damage.
-

Infographic – Security Top A.I. Application
As more businesses implement artificial intelligence or A.I., in their operations, boosting security is emerging as the leading way to use this technology.
-

Process Devised for Sensor-Fitted Personal Prosthetics
Biomedical engineers developed techniques to produce low-cost personalized electronic-enabled prosthetic devices for people with limb loss.
-

NIH Launches Universal Flu Vaccine Trial
A clinical trial testing a vaccine designed to prevent infections from many influenza strains is underway at National Institutes of Health.